Tenax Therapeutics (TENX) Net Cash Flow: 2010-2017
Historic Net Cash Flow for Tenax Therapeutics (TENX) over the last 7 years, with Dec 2017 value amounting to -$159,073.
- Tenax Therapeutics' Net Cash Flow fell 101.70% to -$159,073 in Q4 2017 from the same period last year, while for Dec 2017 it was -$8.4 million, marking a year-over-year decrease of 230.39%. This contributed to the annual value of $85.1 million for FY2024, which is 1009.27% up from last year.
- Latest data reveals that Tenax Therapeutics reported Net Cash Flow of -$159,073 as of Q4 2017, which was up 66.14% from -$469,803 recorded in Q3 2017.
- Tenax Therapeutics' 5-year Net Cash Flow high stood at $9.4 million for Q4 2016, and its period low was -$36.4 million during Q3 2014.
- Over the past 3 years, Tenax Therapeutics' median Net Cash Flow value was -$1.3 million (recorded in 2016), while the average stood at -$1.1 million.
- Per our database at Business Quant, Tenax Therapeutics' Net Cash Flow crashed by 1,205.42% in 2014 and then soared by 9,458.99% in 2016.
- Quarterly analysis of 5 years shows Tenax Therapeutics' Net Cash Flow stood at $2.5 million in 2013, then tumbled by 398.93% to -$7.6 million in 2014, then soared by 88.24% to -$100,160 in 2015, then spiked by 9,458.99% to $9.4 million in 2016, then tumbled by 101.70% to -$159,073 in 2017.
- Its Net Cash Flow stands at -$159,073 for Q4 2017, versus -$469,803 for Q3 2017 and -$4.8 million for Q2 2017.